封面
市場調查報告書
商品編碼
1983294

組織庫市場:依產品、組織類型和地區分類。

Tissue Banking Market, By Product, By Tissue Type, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

組織庫市場預計2026年達到84.5億美元,預計到2033年將達到150億美元。預計從2026年到2033年,其複合年成長率將達到7.5%。

分析範圍 分析詳情
基準年 2025 市場規模(2026 年) 84.5億美元
效能數據 2020-2024 預測期 2026-2033
預測期(2026-2033 年)複合年成長率 7.50% 預計金額(2033 年) 150億美元

組織庫負責收集、處理、儲存和分發用於移植的組織。低溫組織保存技術的研究以及移植組織的高臨床成功率,促使人們在嚴重燒傷和創傷患者中擴大使用保存的組織。對同種異體移植的需求不斷成長,促使各大燒傷中心建立了院內組織庫。組織庫是一個複雜的系統,需要先進的技術專長和熟練的人員在專用設施中才能正常運作。組織庫是收集和取得人體遺體組織用於醫學研究、教育和同種異體移植的機構。 「組織庫」一詞也可以指在低溫條件下儲存生物醫學組織的場所,但更常用於臨床意義上。低溫組織保存技術的研究以及移植組織的高臨床成功率,促使人們在嚴重燒傷和創傷患者中擴大使用保存的組織。對同種異體移植的需求不斷成長,促使各大燒傷中心建立了院內組織庫。在美國,許多皮膚庫都建在治療燒傷患者的主要醫療機構附近。目前,美國有超過50家皮膚和組織庫在運作。皮膚庫的運作方式是從捐贈者的身體上採集組織,檢測其是否適合作為移植材料,進行包裝和儲存,最終將其重新用作移植材料。

市場動態

組織庫市場成長的主要促進因素包括:對同種異體移植的外科需求不斷增加,全髖關節置換術中對骨移植和股骨頭同種異體移植的需求日益成長,以及燒傷發生率的上升。根據世界衛生組織2018年3月的報告,每年約有18萬人死於燒燙傷,其中大多數發生在低收入和中等收入國家。此外,人口老化也使人們更容易患上老齡化黃斑部病變(AMD)、青光眼和糖尿病視網膜病變等慢性疾病。

私營和公共機構在彌合組織供需缺口方面發揮著至關重要的作用。例如,2017年,MTF Biologics分發了超過55萬份組織移植片,這些移植片得益於5,700位捐贈者的無償捐贈。這些可移植組織在50多個國家幫助挽救了約40萬人的生命。

缺乏訓練有素的專業人員來維護組織庫是阻礙組織庫市場成長的主要因素。例如,根據2018年ALZFORUM的報告,過去50年間,荷蘭腦庫僱用的神經病理學家人人數已從65人減少到約15人。

本報告的主要特點

  • 本報告指出了各個細分市場的潛在商機,並概述了該市場中一系列有吸引力的投資提案。
  • 此外,它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
  • 本節根據以下參數介紹全球組織銀行市場中的主要企業概況:公司概況、產品系列、主要亮點、財務績效和策略。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
  • 《全球組織銀行市場》報告面向該行業的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過分析全球組織銀行市場中使用的各種策略矩陣來促進決策。

目錄

第1章:分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 法規環境
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 市場機遇
  • 法規環境
  • 主要進展
  • 產業趨勢

第4章:全球組織庫市場:依產品分類(2020-2033 年)

  • 文化媒體與消費品
  • 裝置
  • 冷凍保存設備

第5章:全球組織銀行市場:依組織類型分類(2020-2033 年)

  • 腦和脊髓
  • 角膜
  • 心臟瓣膜
  • 皮膚
  • 其他

第6章:全球組織庫市場:按地區分類(2020-2033 年)

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太地區
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第7章 競爭情勢

  • AbD Serotec
  • AMS Biotechnology Limited
  • BioLife Solutions, Inc.
  • Beckman Coulter, Inc.
  • BioCision LLC
  • BioStorage Technologies, Inc.
  • Custom BioGenic Systems
  • Eppendorf AG
  • EMD Millipore Corporation
  • Fisher BioServices, Inc.
  • Genzyme Corporation
  • Hamilton Company
  • Merck KGaA
  • PHC Corporation
  • Teva Pharmaceutical Industries Ltd.

第8章 分析師建議

  • 機會
  • 分析師意見
  • Coherent Opportunity Map (COM)

第9章 參考文獻與分析方法

  • 參考
  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI2600

Tissue Banking Market is estimated to be valued at USD 8.45 Bn in 2026 and is expected to reach USD 15.00 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 8.45 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.50% 2033 Value Projection: USD 15.00 Bn

Tissue banks recover, process, store, and distribute tissue for transplantation. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand for allografts resulted in the establishment of in-house tissue banking activity at major burns centers. Tissue banking organization is a complex system and needs high technical expertise and skilled personnel for proper functioning in a dedicated facility. A tissue bank is an establishment that collects and recovers human cadaver tissue for the purposes of medical research, education and allograft transplantation. A tissue bank may also refer to a location where biomedical tissue is stored under cryogenic conditions and is generally used in a more clinical sense. Research in the field of tissue preservation at low temperature and high clinical success of transplanted tissue led to increase in the use of stored tissue in major burn and trauma patients. Increased demand of allografts resulted in the establishment of in house tissue banking activity at major burns center(s). Large numbers of skin banks were opened near major institutions handling burns patients in the U.S. There are more than fifty operational skin and tissue banks in the U.S. at present. Skin banking is a process in which tissue is removed from a donor's body, tested for suitability as a graft material, packaged and stored and finally reused as a graft.

Market Dynamics

Increasing surgical demands for allografts, demand for bone graft in hip replacements, and femoral head allografts, and increasing incidences of burn patients are the main factors for the growth of the tissue banking market. According to the WHO March 2018 report, about 180,000 deaths are caused by burns every year, majority of the cases occur in low and middle income countries. Moreover, aging population is prone to chronic diseases, such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy.

Private and public organizations are playing crucial role in fulfilling the gap between demand and supply of tissue. For instance, in 2017, MTF Biologics distributed over 550,000 tissue grafts, which was made possible through the selfless donation by 5,700 individuals. These transplantable tissues helped to heal an estimated 400,000 lives in over 50 countries.

Dearth of highly trained professionals to maintain the tissue banks is the major restraining factor for growth of the tissue banking market. For instance, according to ALZFORUM 2018 report, over the last 50 years, the number of neuropathologists on staff at the Netherlands Brain Bank dropped from 65 to about 15.

Key features of the study

  • This report provides an in-depth analysis of the global tissue banking market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global tissue banking market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include AbD Serotec (a Bio-Rad company), AMS Biotechnology Limited, BioLife Solutions, Inc., Beckman Coulter, Inc., BioCision LLC, BioStorage Technologies, Inc., Custom BioGenic Systems, Eppendorf AG, EMD Millipore Corporation, Fisher BioServices, Inc., Genzyme Corporation, Hamilton Company, Merck KGaA, PHC Corporation, and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global tissue banking market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue banking market

Market Segmentation

  • Product Insights (Revenue, USD Bn, 2026 - 2033)
    • Media and Consumables
    • Equipment
    • Cryopreservation Equipment
    • Quality Control Equipment
    • Thawing equipment
    • Others
  • Tissue Type Insights (Revenue, USD Bn, 2026 - 2033)
    • Bone
    • Brain & Spinal Cord
    • Cornea
    • Heart Valves
    • Skin
    • Others
  • Regional Insights (Revenue, USD Bn, 2026 - 2033)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • North Africa
    • Central Africa
    • South Africa
  • Key Players Insights
    • AbD Serotec
    • AMS Biotechnology Limited
    • BioLife Solutions, Inc.
    • Beckman Coulter, Inc.
    • BioCision LLC
    • BioStorage Technologies, Inc.
    • Custom BioGenic Systems
    • Eppendorf AG
    • EMD Millipore Corporation
    • Fisher BioServices, Inc.
    • Genzyme Corporation
    • Hamilton Company
    • Merck KGaA
    • PHC Corporation
    • Teva Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Tissue Banking Market, By Product
    • Global Tissue Banking Market, By Tissue Type
    • Global Tissue Banking Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global Tissue Banking Market, By Product, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Media and Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
    • Segment Trends
  • Cryopreservation Equipment
    • Quality Control Equipment
    • Thawing equipment
    • Others

5. Global Tissue Banking Market, By Tissue Type, 2020-2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Bone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Brain & Spinal Cord
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Cornea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Heart Valves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Skin
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. Global Tissue Banking Market, By Region, 2020 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Tissue Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Tissue Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Tissue Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Tissue Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Tissue Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Tissue Type, 2020 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • AbD Serotec
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AMS Biotechnology Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioLife Solutions, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Beckman Coulter, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioCision LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioStorage Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Custom BioGenic Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eppendorf AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • EMD Millipore Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fisher BioServices, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genzyme Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hamilton Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PHC Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. References and Research Methodology

  • References
  • Research Methodology
  • About us